The need for good regulatory practices and medical device regulatory convergence in the Americas has been put in sharp relief by the COVID-19 epidemic.<\/p>\n\n\n\n
The Coalition has prioritized regulatory matters assisting in the combat of COVID-19 within the context of its vision and mission towards regulatory convergence.<\/p>\n\n\n\n
The Coalition is actively working with key government agencies around the region to identify how the industry can help ensure that providers and patients everywhere have access to the medical technologies they need to help diagnose and fight this deadly virus.<\/p>\n\n\n\n
Since the onset of the COVID-19 outbreak, the Coalition member association companies have donated millions of dollars\u2019 worth of medical products and cash to hospitals, foundations and charities around the world. Medical device companies are responding to increased demand by ramping up production wherever possible, coordinating closely with governments to ensure the delivery of supplies where they are most needed, and in some cases, creating new devices and diagnostic tests to help effectively diagnose and treat sick patients.<\/p>\n\n\n\n
AdvaMed has assembled a collection of some of the efforts undertaken by Coalition Principal Members\u2019 companies based on public statements.<\/p>\n\n\n\n
Read more<\/a><\/p>\n\n\n\n In vitro<\/em> diagnostic (IVD) manufacturers have taken key steps to increase patient access to COVID-19 diagnostic testing in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health.<\/p>\n\n\n\n AdvaMed has compiled a list of companies that have developed IVDs that have received Emergency Use Authorization from the U.S. Food and Drug Administration.<\/p>\n\n\n\n View the list<\/a><\/p>\n\n\n\nIn Vitro<\/em> Diagnostic COVID-19 Tests<\/h2>\n\n\n\n
Diagnostics Resources<\/h2>\n\n\n\n